Compare · EL vs YCBD
EL vs YCBD
Side-by-side comparison of Estee Lauder Companies Inc. (EL) and cbdMD Inc. (YCBD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EL and YCBD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- EL is the larger of the two at $30.96B, about 3742.9x YCBD ($8.3M).
- EL has been more active in the news (8 items in the past 4 weeks vs 4 for YCBD).
- EL has more recent analyst coverage (25 ratings vs 0 for YCBD).
- Company
- Estee Lauder Companies Inc.
- cbdMD Inc.
- Price
- $85.55-3.80%
- $0.79-4.97%
- Market cap
- $30.96B
- $8.3M
- 1M return
- +11.41%
- -
- 1Y return
- +28.34%
- -
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- AMEX
- IPO
- 1995
- 2017
- News (4w)
- 8
- 4
- Recent ratings
- 25
- 0
Estee Lauder Companies Inc.
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company offers a range of skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, cleansing devices, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as compacts, brushes, and other makeup tools. It also provides fragrance products in various forms comprising eau de parfum sprays and colognes, as well as lotions, powders, creams, candles, and soaps; and hair care products that include shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company offers its products under Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, By Kilian, BECCA, Too Faced, Dr. Jart+, DECIEM, and The Ordinary brands. It also holds license arrangements for Tommy Hilfiger, Donna Karan New York, DKNY, Michael Kors, and Ermenegildo Zegna brands. The company sells its products through department stores, specialty-multi retailers, upscale perfumeries and pharmacies, and salons and spas; freestanding stores; its own and authorized retailer websites; third-party online malls; stores in airports; and in-flight and duty-free shops. The company was founded in 1946 and is headquartered in New York, New York.
cbdMD Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.
Latest EL
- SEC Form SD filed by Estee Lauder Companies Inc.
- The Estée Lauder Companies to Participate in the dbAccess Global Consumer Conference
- The Estée Lauder Companies & Puig End Discussions Regarding a Potential Business Combination
- SEC Form 4 filed by Director Fribourg Paul J
- SEC Form 4 filed by Director Zinterhofer Eric Louis
- SEC Form 4 filed by Director Sternlicht Barry S
- Piper Sandler resumed coverage on Estee Lauder with a new price target
- The Estée Lauder Companies to Participate in the Morgan Stanley Luxury Conference
- Telsey Advisory Group reiterated coverage on Estee Lauder with a new price target
- SEC Form 10-Q filed by Estee Lauder Companies Inc.
Latest YCBD
- cbdMD Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
- SEC Form 10-Q filed by cbdMD Inc.
- cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results
- Hawkeye Systems Announces New Board Members With Deep Capital Markets, Governance, Legal, and Merchant Banking Experience
- SEC Form 4 filed by Porter Jeffrey H
- SEC Form 4 filed by Roe Kevin Charles
- SEC Form 4 filed by Swift Sibyl Nichole
- SEC Form 4 filed by Sellers Bakari T.
- SEC Form 4 filed by Stephen Scott G.